WE'RE READY TO HELP YOU PROTECT YOUR PATIENTS FROM FLU

Sanofi Pasteur is a world leader in research, development and manufacturing of influenza vaccines. More than 3.5 billion doses of Sanofi Pasteur seasonal influenza vaccines have been distributed worldwide.1

Sanofi Pasteur's Quadrivalent Influenza vaccine (split virion, inactivated)▼QIV includes both B lineages that have the potential to circulate in the UK, alongside the chosen A strains.2

Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.

QIV Prescribing information

View the QIV SmPC

You will receive personal support from a Vaccine Account Manager who is there to provide help whenever you need it.

We can supply a range of materials for you to promote your influenza vaccination campaign to your patients.

Sanofi Pasteur is ready to be your trusted vaccine partner, helping you to protect your patients.

References:

  1. Sanofi Pasteur. Leading provider of seasonal influenza vaccines. Fact sheet. Press Release
  2. Sanofi Pasteur 2018. Quadrivalent Influenza vaccine (split virion, inactivated) Summary of Product Characteristics. August 2018

 

Date of preparation: November 2018 | SAGB.MIS.18.08.1323ac